3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Neoplasm Metastasis
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Neuroepithelial
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Epstein-Barr Virus Infections
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Cisplatin
28
Radiotherapy
20
pembrolizumab
9
Paclitaxel
9
Surveys and Questionnaires
8
Cetuximab
8
Fluorouracil
7
Docetaxel
7
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
apatinib
5
Low-Level Light Therapy
5
Blood Specimen Collection
5
durvalumab
4
Standard of Care
4
Magnetic Resonance Imaging
4
Gemcitabine
4
Cyclophosphamide
4
Celecoxib
4
Tegafur
3
Radiation
3
Oncolytic Virotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lidocaine
3
Immunoenzyme Techniques
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
Biopsy
3
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Head and Neck Neoplasms
×
Valproic Acid
×
Clear all
NCT02624128
2023-11-13
V-CHANCE
National Cancer Institute, Naples
Phase 2
Unknown
39 enrolled